Wood LD - Search Results

1

Nurse identified hospital to home medication discrepancies: implications for improving transitional care.

Corbett CF, Setter SM, Daratha KB, Neumiller JJ, Wood LD. Corbett CF, et al. Among authors: wood ld. Geriatr Nurs. 2010 May-Jun;31(3):188-96. doi: 10.1016/j.gerinurse.2010.03.006. Geriatr Nurs. 2010. PMID: 20525523

2

Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.

Wood LD, Neumiller JJ, Setter SM, Dobbins EK. Wood LD, et al. Am J Geriatr Pharmacother. 2010 Aug;8(4):294-315. doi: 10.1016/j.amjopharm.2010.08.002. Am J Geriatr Pharmacother. 2010. PMID: 20869620 Review.

3

Challenges of medication management in hospitalized patients with Parkinson's disease.

Wood LD, Neumiller JJ, Carlson J, Setter SM, Corbett CF. Wood LD, et al. Am J Health Syst Pharm. 2010 Dec 1;67(23):2059-63. doi: 10.2146/ajhp100170. Am J Health Syst Pharm. 2010. PMID: 21098379 No abstract available.

4

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes.

Neumiller JJ, Sonnett TE, Wood LD, Setter SM, Campbell RK. Neumiller JJ, et al. Among authors: wood ld. Diabetes Metab Syndr Obes. 2010 Jul 14;3:215-26. Diabetes Metab Syndr Obes. 2010. PMID: 21437090 Free PMC article.

5

A review of inhaled technosphere insulin.

Neumiller JJ, Campbell RK, Wood LD. Neumiller JJ, et al. Among authors: wood ld. Ann Pharmacother. 2010 Jul-Aug;44(7-8):1231-9. doi: 10.1345/aph.1P055. Epub 2010 Jun 1. Ann Pharmacother. 2010. PMID: 20516362 Review.

6

Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.

Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A. Setter SM, et al. Consult Pharm. 2009 Jul;24(7):524-37. doi: 10.4140/tcp.n.2009.524. Consult Pharm. 2009. PMID: 19689181 Review.

7

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.

Neumiller JJ, Wood L, Campbell RK. Neumiller JJ, et al. Pharmacotherapy. 2010 May;30(5):463-84. doi: 10.1592/phco.30.5.463. Pharmacotherapy. 2010. PMID: 20411998 Review.

8

Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson's disease.

Wood LD. Wood LD. Drugs Aging. 2010 Apr 1;27(4):295-310. doi: 10.2165/11318330-000000000-00000. Drugs Aging. 2010. PMID: 20359261 Review.

9

Understanding familial risk of pancreatic ductal adenocarcinoma.

Paranal RM, Wood LD, Klein AP, Roberts NJ. Paranal RM, et al. Among authors: wood ld. Fam Cancer. 2024 Apr 12. doi: 10.1007/s10689-024-00383-2. Online ahead of print. Fam Cancer. 2024. PMID: 38609521 Review.

10

Transfer learning reveals cancer-associated fibroblasts are associated with epithelial-mesenchymal transition and inflammation in cancer cells in pancreatic ductal adenocarcinoma.

Guinn S, Kinny-Köster B, Tandurella JA, Mitchell JT, Sidiropoulos DN, Loth M, Lyman MR, Pucsek AB, Zabransky DJ, Lee JW, Kartalia E, Ramani M, Seppälä TT, Cherry C, Suri R, Zlomke H, Patel J, He J, Wolfgang CL, Yu J, Zheng L, Ryan DP, Ting DT, Kimmelman AC, Gupta A, Danilova L, Elisseeff JH, Wood LD, Stein-O'Brien G, Kagohara LT, Jaffee EM, Burkhart RA, Fertig EJ, Zimmerman JW. Guinn S, et al. Among authors: wood ld. Cancer Res. 2024 Apr 8. doi: 10.1158/0008-5472.CAN-23-1660. Online ahead of print. Cancer Res. 2024. PMID: 38587552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page